Risk Prediction of Hepatocellular Carcinoma After Hepatitis B Surface Antigen Seroclearance in Patients With Chronic Hepatitis B
Alimentary Pharmacology & Therapeutics2026
Shuaibing Ying, Jinyao Dai, Qiudan Zhang, Yujing Wang, Yina Yu, Z. Zhang, S.J. Dong, Yichun Zhang, Haoyang Hu, Yuqi Hong, Yi Liu, Yu Guo, Haomin Yan, Yunqing Qiu, Yan Lou
Abstract
The independent risk factors of HCC occurrence are age ≥ 50 years, male, platelet count≤ 150 × 109/L, albumin level ≤ 44 g/L, with cirrhosis at HBsAg seroclearance and AVT-induced HBsAg seroclearance. Our six-factor model enables risk stratification among patients achieving HBsAg seroclearance and may assist in informing surveillance strategies in clinical practice.